chr5-119536458-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000414.4(HSD17B4):c.2029C>T(p.Gln677Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,460,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000414.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSD17B4 | NM_000414.4 | c.2029C>T | p.Gln677Ter | stop_gained | 23/24 | ENST00000510025.7 | NP_000405.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSD17B4 | ENST00000510025.7 | c.2029C>T | p.Gln677Ter | stop_gained | 23/24 | 2 | NM_000414.4 | ENSP00000424940 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251098Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135704
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460068Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 726380
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bifunctional peroxisomal enzyme deficiency Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 15, 2017 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) | Apr 01, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 20, 2019 | Variant summary: HSD17B4 c.2029C>T (p.Gln677X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 251098 control chromosomes (gnomAD). c.2029C>T has been reported in the literature in a homozygous individual affected with D-Bifunctional Protein Deficiency type I (Ferdinandusse_2006). This study also reported experimental evidence evaluating an impact on protein function, and demonstrated the complete lack of protein and enzymatic activity in patient derived fibroblasts (Ferdinandusse_2006). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Bifunctional peroxisomal enzyme deficiency;C0685838:Perrault syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2019 | Loss-of-function variants in HSD17B4 are known to be pathogenic (PMID: 11810648, 16385454). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individuals affected with D-bifunctional protein deficiency (PMID: 16385454). This variant is present in population databases (rs751646311, ExAC 0.002%). This sequence change creates a premature translational stop signal (p.Gln677*) in the HSD17B4 gene. It is expected to result in an absent or disrupted protein product. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at